Company / Operating Income
Ginkgo Bioworks Holdings, Inc. Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$315.3M
FY2025
5-year range
-$2.2B / -$315.3M
FY2021-FY2025
Trend
+43.7%
vs FY2024
Sector context
#164 of 202
Health Care
What the data says
Ginkgo Bioworks Holdings, Inc.'s operating income of -$315M is lower than 81% of companies in the Health Care sector (FY2025). Operating Income has increased for 3 consecutive years, from -$2.2B in FY2022 to -$315M in FY2025.
Based on SEC 10-K filings.
-$315M in FY2025.
Improved from -$864M to -$315M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 202This company -$315.3M Sector average $86.7M
▼
-463.8% below sector average
Key checks
Key Insights
- Ginkgo Bioworks Holdings, Inc.'s operating income has grown for 3 consecutive years.
- In FY2025, operating income increased 43.7% year-over-year.
- Ranks #164 out of 202 companies in the Health Care sector.
- Peak operating income was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$315.3M | +43.7% |
| FY2024 | -$559.8M | +35.2% |
| FY2023 | -$864.4M | +60.9% |
| FY2022 | -$2.2B | -20.8% |
| FY2021 | -$1.8B | -1234.4% |
| FY2020 | -$137.0M | -91.4% |
| FY2019 | -$71.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026